Day 4 Recap: SDPA Annual Summer Dermatology Conference 2025

To stay informed with the latest conference insights, subscribe to receive our eNewsletters.

Maria Hordinsky, MD: Early Clue in Scarring Alopecia May Change Clinical Approach

Maria Hordinsky, MD, urges dermatology clinicians to consider allergic contact dermatitis when scarring alopecia treatments fail.

Clinical Pearls on JAK Inhibitor Utility and Research From Eileen Cheever, MPAS, PA-C

Eileen Cheever, MPAS, PA-C, highlights the growing role of JAK inhibitors in dermatology, including emerging data on prurigo nodularis and adolescent alopecia areata.

7-Year Safety Review Confirms Brodalumab’s Steady Risk Profile in US Postmarketing Surveillance

A poster from SDPA 2025 showed brodalumab maintains a consistent safety profile with no completed suicides and low infection rates.

What’s Shaping the Future of Alopecia Treatment, According to Today’s Clinicians

From JAK inhibitors to trichoscopy and contact allergy clues, experts at SDPA 2025 shared their top clinical pearls for managing alopecia and hair loss.

Dermatology Times' Weekly Crossword: SDPA Summer Edition

Test your knowledge of key words, terms, and pearls associated with this weekend's SDPA Annual Summer Dermatology Conference.

Top KOL Insights From SDPA Summer 2025

Expert our review of the top pearls, clinical strategies, and practice-changing tips from leading voices in dermatology at SDPA’s 2025 Summer Conference.

Make sure to keep up to date with the latest in coverage from the conference and subscribe to Dermatology Times to receive daily email updates.